Dr. Goy on Advancements in Relapse/Refractory Mantle Cell Lymphoma OncLive 1:08 7 years ago 95 Скачать Далее
Dr. Goy on Combinations With Novel Agents in Relapsed/Refractory MCL OncLive 1:05 4 years ago 79 Скачать Далее
Dr. Goy the Evolution of Treatment in Relapsed/Refractory MCL OncLive 1:20 4 years ago 59 Скачать Далее
BTK Inhibitors Improve Responses Relapsed/Refractory Mantle Cell Lymphoma Targeted Oncology 1:33 4 years ago 143 Скачать Далее
Dr. Goy Discusses Long-Term Follow-Up Results for Ibrutinib in MCL Targeted Oncology 1:56 6 years ago 111 Скачать Далее
Relapsed/Refractory Mantle Cell Lymphoma Lymphoma Research Foundation 7:51 1 year ago 963 Скачать Далее
How to Treat Patients With Relapsed/Refractory Mantle Cell Lymphoma Targeted Oncology 1:56 4 years ago 253 Скачать Далее
Dr. Goy on the Role of Immunotherapy in Mantle Cell Lymphoma OncLive 1:27 7 years ago 225 Скачать Далее
Dr. Goy Discusses the Approval of Revlimid for Patients with Relapsed or Refractory MCL Targeted Oncology 1:38 10 years ago 146 Скачать Далее
Dr. Goy on the Evolution of Treatment in Mantle Cell Lymphoma OncLive 1:34 6 years ago 203 Скачать Далее
Dr. Goy on Takeaways in Mantle Cell Lymphoma for the Future OncLive 0:44 7 years ago 120 Скачать Далее
Dr. Goy on the Combination of Biological Therapies in Relapsed MCL OncLive 1:27 5 years ago 70 Скачать Далее
